✦ LIBER ✦

O-113 Clinical evaluation of gefitinib (Iressa, ZD1839) in combination with rofecoxib in cisplatin pre-treated relapsed non-small cell lung cancer

✍ Scribed by O'Byrne, K.J.; Clarke, L.; Dunlop, D.; Ranson, Malcolm; Danson, S.; Botwood, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-243 Clinical benefits in patients with

✍ Janne, Pasi A.; Gurubhagavatula, Sarada; Lucca, Joan; Ostler, Patricia; Skarin, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Activity of ZD1839 (Gefitinib, Iressa™)

✍ Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB

Effect of gefitinib (‘Iressa’, ZD1839) o

✍ Hotta, Katsuyuki; Kiura, Katsuyuki; Ueoka, Hiroshi; Tabata, Masahiro; Fujiwara, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Gefitinib (ZD1839, Iressa®) in non-small

✍ Fabrice Barlési; Cécile Tchouhadjian; Christophe Doddoli; Patrick Villani; Laure 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Effects of ZD1839 (Iressa, gefitinib) tr

✍ Ronald B Natale 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 240 KB

P-624 A pilot trial of gefitinib (‘Iress

✍ Manegold, C.; Gatzemeier, U.; Buchhoiz, E.; Smith, R.; Averbuch, S.; Fandi, A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB